LEXINGTON, Mass., Jan. 30, 2020 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PUR1900 (“Pulmazole”), the Company’s inhaled itraconazole antifungal candidate […]
» Read moreThe trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according […]
» Read moreOne in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm, the official […]
» Read moreAn estimated 46.6 million U.S. adults struggle with mental illnesses, such as anxiety disorder, according to the National Institute of Mental Health. About half of millennials and 75% of Gen-Zers […]
» Read moreA marijuana plant extract, also known as cannabidiol (CBD), is being commonly used to improve anxiety, sleep problems, pain, and many other neurological conditions. Now UNC School of Medicine researchers […]
» Read more(HealthDay)—There is an increased risk for gallbladder- or biliary tract-related events among patients with type 2 diabetes taking liraglutide versus placebo, according to a study published online Aug. 9 in […]
» Read moreThe Food and Drug Administration’s (FDA) Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market. New research to be published […]
» Read moreTo combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can prolong the drug’s […]
» Read more(HealthDay)—Overall, 11.9 percent of patients diagnosed with an ankle sprain fill an opioid prescription within seven days of diagnosis, according to a research letter published online July 9 in the […]
» Read moreIt’s an unforeseen side effect of the nation’s opioid epidemic: Adolescent heroin users. A USC study in the July 8 issue of JAMA Pediatrics shows that teens who use prescription […]
» Read more
